Related references
Note: Only part of the references are listed.Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine - an updated systematic review and meta-analysis
Hong Deng et al.
BMC NEUROLOGY (2020)
Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans
Tessa de Vries et al.
PHARMACOLOGY & THERAPEUTICS (2020)
CGRP inhibitors for migraine prophylaxis: a safety review
Eduardo Rivera-Mancilla et al.
EXPERT OPINION ON DRUG SAFETY (2020)
Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine
Jeanine L. Bussiere et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2019)
CGRP Is Critical for Hot Flushes in Ovariectomized Mice
Daniel B. Wilhelms et al.
FRONTIERS IN PHARMACOLOGY (2019)
Is calcitonin gene-related peptide a modulator of menopausal vasomotor symptoms?
Maria Alice Oliveira et al.
ENDOCRINE (2019)
Gender aspects of CGRP in migraine
Alejandro Labastida-Ramirez et al.
CEPHALALGIA (2019)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine
Kasra Maasumi et al.
DRUGS (2018)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina
Christophe Depre et al.
HEADACHE (2018)
Female sex hormones in men with migraine
Willebrordus P. J. van Oosterhout et al.
NEUROLOGY (2018)
Is CGRP Receptor Blockade Cardiovascularly Safe? Appropriate Studies Are Needed
A. Maassen van den Brink et al.
HEADACHE (2018)
Erenumab (AMG 334) in episodic migraine Interim analysis of an ongoing open-label study
Messoud Ashina et al.
NEUROLOGY (2017)
Wiping Out CGRP: Potential Cardiovascular Risks
Antoinette MaassenVanDenBrink et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Reduced trigeminovascular cyclicity in patients with menstrually related migraine
Khatera Ibrahimi et al.
NEUROLOGY (2015)
Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP
Marcelo E. Bigal et al.
CEPHALALGIA (2014)
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
David W. Dodick et al.
LANCET NEUROLOGY (2014)
CALCITONIN GENE-RELATED PEPTIDE: PHYSIOLOGY AND PATHOPHYSIOLOGY
F. A. Russell et al.
PHYSIOLOGICAL REVIEWS (2014)
Sex Differences in the Prevalence, Symptoms, and Associated Features of Migraine, Probable Migraine and Other Severe Headache: Results of the American Migraine Prevalence and Prevention (AMPP) Study
Dawn C. Buse et al.
HEADACHE (2013)
Angina with normal coronary arteries: Sex differences in outcomes
Karin H. Flumpbries et al.
AMERICAN HEART JOURNAL (2008)
Effects of menopausal status on circulating calcitonin gene-related peptide and adipokines: implications for insulin resistance and cardiovascular risks
P. Gupta et al.
CLIMACTERIC (2008)
Expression of calcitonin gene-related peptide, adrenomedullin, and receptor modifying proteins in human adipose tissue and alteration in their expression with menopause status
Pratima Gupta et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2007)
Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen
E. A. MacGregor et al.
NEUROLOGY (2006)
Circulating calcitonin gene-related peptide and its placental origins in normotensive and preeclamptic pregnancies
Yuan-Lin Dong et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers
KA Petersen et al.
CEPHALALGIA (2005)
The menopausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project
JR Guthrie et al.
CLIMACTERIC (2004)
Involvement of calcitonin gene-related peptide in control of human fetoplacental vascular tone
YL Dong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Calcitonin gene-related peptide in pregnancy and its emerging receptor heterogeneity
C Yallampalli et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2002)
Infusion of pregnant rats with calcitonin gene-related peptide (CGRP)8-37, a CGRP receptor antagonist, increases blood pressure and fetal mortality and decreases fetal growth
PRR Gangula et al.
BIOLOGY OF REPRODUCTION (2002)
CGRP may play a causative role in migraine
LH Lassen et al.
CEPHALALGIA (2002)
Concentrations of calcitonin gene-related peptide and neuropeptide Y in plasma increase during flushes in postmenopausal women
YAM Wyon et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2000)
Share Paper
